| ACovPid | Against Virus | Inhibition Value Type | Inhibitory Effect | Inhibitory Unit | Target Domain Name | Detail |
|---|---|---|---|---|---|---|
| ACoVP100121 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | EC50 | >50 | µM | HR1 domain of SARS-CoV | more |
| ACoVP100122 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | EC50 | >50 | µM | HR1 domain of SARS-CoV | more |
| ACoVP100123 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | EC50 | >50 | µM | HR1 domain of SARS-CoV | more |
| ACoVP100124 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | EC50 | >50 | µM | HR1 domain of SARS-CoV | more |
| ACoVP100125 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | EC50 | 17 ± 3.0 | µM | HR1 domain of SARS-CoV | more |
| ACoVP100126 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | EC50 | 34 ± 4.0 | µM | HR1 domain of SARS-CoV | more |
| ACoVP100127 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | EC50 | >50 | µM | HR1 domain of SARS-CoV | more |
| ACoVP100128 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | EC50 | >50 | µM | HR1 domain of SARS-CoV | more |
| ACoVP100129 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | EC50 | >50 | µM | HR1 domain of SARS-CoV | more |
| ACoVP100130 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | EC50 | >50 | µM | HR1 domain of SARS-CoV | more |
| ACoVP100131 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | EC50 | >50 | µM | HR1 domain of SARS-CoV | more |
| ACoVP100132 | Murine coronavirus (strain A59) (MHV-A59) (Murine hepatitis virus) : 11142 | EC50 | >50 | µM | HR1 domain of MHV-A59 | more |
| ACoVP100133 | Murine coronavirus (strain A59) (MHV-A59) (Murine hepatitis virus) : 11142 | EC50 | 0.9 ± 0.1 | µM | HR1 domain of MHV-A59 | more |
| ACoVP100134 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1) : 1263720 | IC50 | ~0.8 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100135 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1) : 1263720 | IC50 | 0.6 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100136 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1) : 1263720 | IC50 | 0.6 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100137 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1) : 1263720 | IC50 | 13.9 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100138 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1) : 1263720 | IC50 | 0.93 ± 0.15 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100139 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1) : 1263720 | IC50 | 0.85 ± 0.08 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100140 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1) : 1263720 | IC50 | 0.55 ± 0.04 | µM | HR1 domain of SARS-CoV-2 | more |